NAPA, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Utah in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers.

WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today advised consumers not to use certain respiratory medications purchased after Sept.

Federal officials are warming consumers not to use certain respiratory medications purchased after Sept. 8, produced by Dey L.P., a subsidiary of Mylan Inc. The U.S.

NAPA, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc.

PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Dey L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today announced that it has begun to market and distribute EMSAM(R) in the U.S. EMSAM, a selegiline transdermal system, is a monoamine oxidase inhibitor (MAOI), which was approved by the U.S.